We are moving!

From December 16th 2019 you can find us at our new office at Großer Burstah 25, 20457 Hamburg. 



October 2019: We will participate at CPhI 2019 in Frankfurt/ Main, November 05-07. Find us at the booth of SamChunDang (SCD) Pharm. Co., Ltd. (No. 90B60, Korea Pavilion).

October 2019: After the successful EU-GMP registration of our laboratory through the local authorities we can now provide you EU-release services. 

September 2019: We are happy to announce the successful Europe-wide approval of Fulvestrant pre-filled syringes. 

April 18th, 2019: actrevo GmbH and our partner BioQ Pharma will be participating at DAC (Deutscher Anästhesiecongress) in Leipzig, May 9-11. Find us at booth No. 99 to learn more about us!

February 1st, 2019: Product launch Ropivacaine ReadyfusOR in Germany:

Ropivacaine ReadyfusOR (250 ml of Ropivacaine 0.2%),

September 26, 2018: We are participating at CPhI 2018 in Madrid, October 9-11Find us at the booth of SamChunDang (SCD) Pharm. Co., Ltd. (Stand No. 12G41).

September 4th, 2018: actrevo GmbH and our partner BioQ Pharma will be participating at HAI 2018 in Berlin, September 20-21. Find us at booth No. 40 to learn more about us. 


We would also like to invite all interested anesthesiologists and visitors to discuss the treatment of postoperative pain with local anesthetics at our HAI satellite symposiumWie können postoperative Schmerzen erfolgreich opioidsparend behandelt werden?

Friday, September 21, 10 – 11:30 am, room 5

September 2018: together with our business partner BioQ Pharma we are preparing the launch of a new product in the field of anesthesia in Germany: Ropivacain ReadyfusOR - a novel infusion system for postoperative pain management

Please contact us for more information.

June 2018: We are proud to announce that to this date the actrevo team successfully guided 2 Korean companies through their first

EU GMP inspection. We will continue to provide our expertise and experience and support our partners to access the international human and veterinary healthcare market.

October 17, 2017: Participation at BIO-Europe® 2017, Berlin, November 06-08. Find us at the booth of Life Science Nord e.V. (Hall B, booth No. 88).

October 11, 2017: Participation at CPhI 2017 in Frankfurt/ Main, October 24-26. Find us at the booth of SamChunDang (SCD) Pharm. Co., Ltd. (No. 90G59, Korea Pavilion)

February 14, 2017: actrevo is going to participate at DCAT Week 2017 in New York (March 20-23);

January 1st, 2017: Establishment of own pharmaceutical development laboratory in Hamburg

November 1st, 2016: Product launch Hialurom in Germany:

Hialurom (30 mg/2 ml sodium hyaluronate, pre-filled syringe),

November 1st, 2016: Product launch Hialurom Tendon in Germany: Hialurom Tendon (40 mg/2 ml sodium hyaluronate, pre-filled syringe),

November 1st, 2016: Product launch Hialurom Hondro in Germany: Hialurom Hondro (60 mg/3 ml sodium hyaluronate + 90 mg/3 ml chondroitin sodium sulphate, pre-filled syringe),

July 13, 2016: actrevo is going to participate at CPhI worldwide in Barcelona (October 04-06);

May 05th, 2016: 1st birthday actrevo GmbH

April 22, 2016: actrevo was registered as pharmaceutical entrepreneur (pharmazeutischer Unternehmer)

March 10, 2016: the official wholesale license certification (Großhandelserlaubnis) was issued to actrevo

February 19, 2016: actrevo will participate at euroPLX 60 in Barcelona (March 07 and 08);

November 12, 2015: Participation at Medica, Düsseldorf in November 2015;

October, 29, 2015: actrevo became member of Gesundheitsmetropole e.V.;

October 5, 2015: actrevo became member of Life Science Nord;

September 11, 2015: Participation at CPhI Worldwide in Madrid in October 2015;

September 2, 2015: actrevo established new offices in Hamburg. Our new address is Neuer Wall 54, 20354 Hamburg, Germany.